We are live on
!
Find out more
AP
Antipodes Partners Portfolio holdings
AUM
$5.19B
1-Year Est. Return
36.17%
This Fund
S&P 500
This Quarter
Est. Return
+12.71%
1 Year Est. Return
+36.17%
3 Year Est. Return
+104%
5 Year Est. Return
+169.34%
10 Year Est. Return
–
AUM
$3.2B
AUM Growth
+$89.5M
(+2.9%)
Cap. Flow
-$255M
Cap. Flow
% of AUM
-7.95%
Top 10 Holdings %
Top 10 Hldgs %
49.47%
Holding
83
New
14
Increased
26
Reduced
28
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutrien
NTR
|
+$89.7M |
| 2 |
Global Payments
GPN
|
+$62.6M |
| 3 |
Occidental Petroleum
OXY
|
+$48.7M |
| 4 |
Agnico Eagle Mines
AEM
|
+$37.9M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$32.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$135M |
| 2 |
Stellantis
STLA
|
+$119M |
| 3 |
Seagate
STX
|
+$54.9M |
| 4 |
FYBR
Frontier Communications
FYBR
|
+$51.9M |
| 5 |
PagSeguro Digital
PAGS
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 14.7% |
| 2 | Technology | 14.68% |
| 3 | Communication Services | 14.63% |
| 4 | Healthcare | 13.76% |
| 5 | Consumer Discretionary | 10.44% |
Similar funds
MS
AUB
KACA
DDC
MIM
AAI
SCM
SDIC
Antipodes Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Antipodes Partners held 83 positions worth $3.2B, up 2.9% from $3.11B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Antipodes Partners withdrew a net $255M in Q4 2023, closing 11 positions and reducing 28 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $135M position sold in full.
By sector, the portfolio is most concentrated in Materials at 15% of assets, up from 9.4% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Antipodes Partners opened a new position in Global Payments worth $68.7M.
- Antipodes Partners's largest Q4 2023 buy was Global Payments: 540,770 shares worth $68.7M.
- Antipodes Partners added most to Nutrien in Q4 2023, an estimated $89.7M increase.
- Antipodes Partners's biggest Q4 2023 reduction was Stellantis, cutting an estimated $119M.
- Antipodes Partners fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $135M.
- Antipodes Partners's ten largest holdings make up 49% of its $3.2B portfolio in Q4 2023.
- Antipodes Partners opened 14 new positions and closed 11 in Q4 2023.
- Antipodes Partners's portfolio value rose 2.9% quarter-over-quarter to $3.2B.
Based on Antipodes Partners's 13F filing for Q4 2023, filed 24 Jan 2024.